Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06513832

Asthma Navigator Intervention to Improve Health Equity in Children

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
75 (estimated)
Sponsor
Emory University · Academic / Other
Sex
All
Age
5 Years – 17 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to improve health equity in children aged 5-16.9 years admitted to the PICU for asthma. The objectives are: * To identify the factors related to differential experiences of asthma self-management * To pilot the effectiveness of an individualized asthma navigator intervention at PICU discharge.

Detailed description

Despite available asthma treatments, nearly 50% of children with asthma experience exacerbations annually, with disadvantaged children, particularly Black and Hispanic, being the most affected. These disparities are largely due to social determinants of health (SDOH), including socioeconomics and family hardship, which explain over 80% of the racial disparities in asthma outcomes. Children in lower opportunity neighborhoods face additional challenges like poor housing and limited green spaces, increasing exposure to pollutants and allergens. At Children's Healthcare of Atlanta's Pediatric ICU (PICU), 85% of asthma admissions come from low-opportunity areas, with 36.7% having another exacerbation within a year. Significant barriers to better outcomes include limited provider understanding of SDOH and challenges in asthma self-management. Effective asthma self-management, supported by medical providers, is crucial for improving health outcomes in these disadvantaged children.

Conditions

Interventions

TypeNameDescription
BEHAVIORALThe asthma navigatorThe asthma navigator is a Registered Respiratory Therapist and Certified Asthma Educator who will review the care plan at discharge and provide asthma education; assist with follow-up clinic appointment scheduling, medication access, and transportation; and daily as-needed telephone support.

Timeline

Start date
2025-01-17
Primary completion
2026-08-01
Completion
2026-08-01
First posted
2024-07-22
Last updated
2026-02-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06513832. Inclusion in this directory is not an endorsement.